<SEC-DOCUMENT>0001193125-19-145975.txt : 20190514
<SEC-HEADER>0001193125-19-145975.hdr.sgml : 20190514
<ACCEPTANCE-DATETIME>20190514073032
ACCESSION NUMBER:		0001193125-19-145975
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20190514
FILED AS OF DATE:		20190514
DATE AS OF CHANGE:		20190514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DBV Technologies S.A.
		CENTRAL INDEX KEY:			0001613780
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36697
		FILM NUMBER:		19820429

	BUSINESS ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
		BUSINESS PHONE:		33(0)155427878

	MAIL ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d701620d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN PRIVATE ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-16</FONT> OR
<FONT STYLE="white-space:nowrap">15d-16</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the Month of May 2019 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-36697</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>DBV TECHNOLOGIES S.A. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>92120 Montrouge France </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT STYLE="white-space:nowrap">40-F:</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9746;&nbsp;&nbsp;Form
<FONT STYLE="white-space:nowrap">20-F&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;&nbsp;Form</FONT> <FONT STYLE="white-space:nowrap">40-F</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT LIST </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated May&nbsp;14, 2019.</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>DBV TECHNOLOGIES S.A.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: May&nbsp;14, 2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ David Schilansky</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Schilansky</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deputy Chief Executive Officer</P></TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g7016201.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g7016202new.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g7016203new.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Technologies Announces Departure
of Deputy CEO David Schilansky </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies (Euronext: DBV &#150; ISIN: FR0010417345 &#150; Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today announced that its Deputy Chief Executive Officer and Principal Financial Officer, David Schilansky, has decided to leave the company to pursue other professional opportunities. David will remain at the Company
through August 2019. While a new Chief Financial Officer search is underway, DBV will not fill the Deputy CEO role following David&#146;s departure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David joined the organization in 2011 as Chief Financial Officer and was subsequently promoted to Deputy Chief Executive Officer and Chief Operating Officer
in January 2015. David has been responsible throughout the period, as Principal Financier, for all financial activities and will remain as such through August 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;I want to take this opportunity to recognize David&#146;s accomplishments and to thank him for his many important contributions to DBV, including
during this important transition as we evolved from a French based research and development company into a potential global commercial-stage organization,&#148; </I>said <B>Daniel Tass&eacute;</B>, Chief Executive Officer of DBV Technologies.<I>
&#147;On behalf of all DBV employees, and personally, I wish him success in his future endeavors.&#148; </I> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About DBV Technologies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies is developing Viaskin<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, a proprietary technology platform with broad potential
applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT&reg;, DBV&#146;s method of delivering biologically active compounds to the immune system through intact skin. With this new class of self-administered and <FONT
STYLE="white-space:nowrap">non-invasive</FONT> product candidates, the Company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments. DBV&#146;s food allergies programs include ongoing
clinical trials of Viaskin Peanut and Viaskin Milk, and preclinical development of Viaskin Egg. DBV is also pursuing a human <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> clinical study of Viaskin
Milk for the treatment of Eosinophilic Esophagitis, and exploring potential applications of its platform in vaccines and other immune diseases. DBV Technologies has global headquarters in Montrouge, France and New York, NY. The Company&#146;s
ordinary shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), part of the SBF120 index, and the Company&#146;s ADSs (each representing <FONT STYLE="white-space:nowrap">one-half</FONT> of one ordinary share) are
traded on the Nasdaq Global Select Market (Ticker: DBVT). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Investor Relations Contact </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sara Blum Sherman </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">@DBV Technologies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">facebook.com/DBVTechnologies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">www.dbv-technologies.com</TD></TR></TABLE>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g7016201.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g7016202new.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director, Investor Relations&nbsp;&amp; Strategy </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-271-0740</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">sara.sherman@dbv-technologies.com</FONT></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Media Contact</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joe Becker </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VP, Global Corporate Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-646-650-3912</FONT></FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT
STYLE="white-space:nowrap">joseph.becker@dbv-technologies.com</FONT></U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">@DBV Technologies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">facebook.com/DBVTechnologies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">www.dbv-technologies.com</TD></TR></TABLE>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g7016201.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g7016201.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M']DXS^3\5_F'_"+ZS_SY'_OM?\:/[3PG\_X/_(/[)QG\GXK_ ##_ (1?6?\
MGR/_ 'VO^-']IX3^?\'_ )!_9.,_D_%?YA_PB^L_\^1_[[7_ !H_M/"?S_@_
M\@_LG&?R?BO\P_X1?6?^?(_]]K_C1_:>$_G_  ?^0?V3C/Y/Q7^8?\(OK/\
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M']DXS^3\5_F'_"+ZS_SY'_OM?\:/[3PG\_X/_(/[)QG\GXK_ ##_ (1?6?\
MGR/_ 'VO^-']IX3^?\'_ )!_9.,_D_%?YA_PB^L_\^1_[[7_ !H_M/"?S_@_
M\@_LG&?R?BO\P_X1?6?^?(_]]K_C1_:>$_G_  ?^0?V3C/Y/Q7^8?\(OK/\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
,!0 4 % !0 4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g7016202new.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g7016202new.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M H * "@#FH03X?U91]\32;OTK5_$C-?"S<T\JVFVI7[OE+C\JSEN6MBS2&%
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MC'L3S1S*X69V$(D$,8F*F4*-Y48!/?%9ECZ "@ H * "@ H * "@ H * "@
$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g7016203new.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g7016203new.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M%M-KH*511DHOK?\  +J^ALY+>.4G?/((T '?U^E$8N6P3FH)-]7;[RS4EA0
MQY8XVC5V"F0[5![G&<?D#32OL)M+<?2&% !0 4 % !0!7O+L6<2MY,DS,X14
MCQDD_4@?K3BKNQ,Y<D;V$MKJ:=RLEA/;@#.Z1HR#[?*QIN*2T9,9RD[.+7W?
MHRS4F@4 % !0 4 17$ZVUM+.X)2)"Y ZX S0M[!L$%S%<6J7,;9B==P)XXIR
M3BVF3":G%2CU&6-[#J%HMS!N\MB0"PQG!(S^E.47!V8J=2-17B6*DL#P.F:
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M\SS] *I63M'S_)_U]YG)2E'FFMFE_P"3*[^?Y)$<G]F;[G^U/+^V^8_E[_\
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MTAA0 4 % !0 4 -D19(VC<95@0<''% "JJHBHHPJC  ["FW=W8DE%60M(84
M5KRS^V*$:XECC(PZ)MPX]#D$_EBJB^5WL1./,K7L6  H  P!P *DI*RLA:!C
H9$62-HW&58$'!QQ0 JJJ(J*,*HP .PIMW=V))15D+2&% !0 4 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
